Navigation Links
Researchers expand cyberspace to fight chronic condition in breast cancer survivors
Date:11/3/2010

COLUMBIA, Mo. Lymphedema is a chronic condition that causes swelling of the limbs and affects physical, mental and social health. It commonly occurs in breast cancer survivors and is the second-most dreaded effect of treatment, after cancer recurrence. Every day, researchers throughout the world learn more about the condition and how it can be treated. Now, University of Missouri researchers are developing a place in cyberspace where relevant and timely information can be easily stored, searched, and reviewed from anywhere with the goal of improving health care through the availability of up-to-date, evidence-based research.

"We want to bring researchers, medical professionals and care providers together to improve patients' health," said Chi-Ren Shyu, principal investigator for the project and director of the MU Informatics Institute. "Merging all of the data into one virtual space and discovering clinically significant knowledge from the haystacks of data will make cutting-edge research and treatments available to patients sooner."

Currently, people looking for information about lymphedema treatment have to visit dozens of medical websites or consult a best practices document, which has not been updated since 2006. The new system will enable immediate access to data, best practices, literature and research from around the world as it is posted online, all in a single, searchable online database.

"The cyber-infrastructure, once complete, can be applied to other diseases and chronic conditions, such as diabetes or cardiovascular disease," Shyu said. "Potential users include researchers, medical professionals, social workers, patients and their families."

Shyu and his informatics team from the College of Engineering are working with Jane Armer, professor in the MU Sinclair School of Nursing and director of the American Lymphedema Framework Project, housed at MU's Ellis Fischel Cancer Center. Their research is funded by a three-year grant awarded by the National Library of Medicine Applied Informatics Program.

In three years, Shyu and Armer plan to complete a system that automatically will pull research findings and new information from scientific journals and association websites through an automated data mining procedure. Shyu has an agreement with selected health care facilities from throughout the country to provide real-time, anonymous patient data so practitioners can understand how patients in different areas of the country are affected by lymphedema and its treatments.

"The development of an informatics depository for a data set holding key information for all patients with lymphedema of any cause offers enormous potential for answering research questions that are difficult to study with small data sets with varying criteria for lymphedema," said Armer. "This cyber-database will help us unlock the door to more immediate access to the latest information on evidence-based treatment and risk-reduction."


'/>"/>

Contact: Emily Martin
MartinEm@missouri.edu
573-882-3346
University of Missouri-Columbia
Source:Eurekalert  

Related medicine news :

1. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
2. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
3. Researchers discover new way to kill pediatric brain tumors
4. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
5. Researchers create drug to keep tumor growth switched off
6. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
7. GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen
8. Clemson researchers develop hands-free texting application
9. Researchers find biomarkers in saliva for detection of early-stage pancreatic cancer
10. Researchers chart genomic map spanning over 2 dozen cancers
11. Researchers discover second protective role for tumor-suppressor
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers expand cyberspace to fight chronic condition in breast cancer survivors
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: